Federated Hermes, Inc. Rvl Pharmaceuticals PLC Transaction History

Federated Hermes, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$3.26 - $4.84 $11,142 - $16,543	-3,418 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$4.12 - $6.29 $387 - $591	94 Added 2.83%	3,418 $14,000
Q3 2020 Nov 12, 2020	BUY	$4.82 - $8.77 $14,946 - $27,195	3,101 Added 1390.58%	3,324 $18,000
Q2 2020 Aug 13, 2020	SELL	$2.83 - $6.99 $933 - $2,306	-330 Reduced 59.67%	223 $2,000
Q1 2020 May 13, 2020	BUY	$3.18 - $7.0 $1,049 - $2,310	330 Added 147.98%	553 $2,000
Q4 2019 Feb 14, 2020	BUY	$3.46 - $7.7 $761 - $1,694	220 Added 7333.33%	223 $2,000
Q3 2019 Nov 14, 2019	BUY	$2.8 - $3.99 $8 - $11	3 New	3 $1,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.